![Roger Perlmutter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Roger Perlmutter
Directeur Général chez
EIKON THERAPEUTICS, INC.
Fortune : 19 M $ au 31/05/2026
Profil
Roger M.
Perlmutter is currently Chairman & Chief Executive Officer at Eikon Therapeutics, Inc. since 2021.
He is Chairman of The Reed Institute since 2012.
He serves as Independent Director at NGM Biopharmaceuticals, Inc. since 2021.
He is Director at the Institute for Systems Biology since 2013 and at Exonics Therapeutics, Inc. since 2018.
He is Independent Director at Insitro, Inc. since 2020.
He is a Science Partner at The Column Group LLC and a Member of the American Academy of Arts & Sciences.
Formerly, Dr. Perlmutter was Chairman-Immunology Department & Professor at the University of Washington from 1984 to 1997.
He was Independent Director at StemCells, Inc. from 2011 to 2013 and at Ablynx NV from 2012 to 2013.
He was President & Director at Alantos Pharmaceuticals Holding, Inc. He was Non-Executive Director at Merck Research Laboratories Massachusetts LLC in 2021.
He was Director at The Irvington Institute for Immunological Research from 1997 to 2001.
He was Non-Executive Director at Nxera Pharma UK Ltd. and Director at Immune Design Corp.
He was Executive Vice President & Head-Research & Development at Amgen, Inc. from 2001 to 2012.
He was Executive Vice President at Merck & Co., Inc. from 2013 to 2021 and EVP-Worldwide Basic & Preclinical Research at Merck & Co., Inc. from 1997 to 2001.
He was President of The American Association of Immunologists.
Education includes a doctorate from Washington University in St. Louis conferred in 1979 and an undergraduate degree from The Reed Institute conferred in 1973.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
EIKON THERAPEUTICS, INC. 3,25 % | 02/03/2026 | 1 760 713 ( 3,25 % ) | 19 M $ | 31/05/2026 |
Postes actifs de Roger Perlmutter
| Sociétés | Poste | Début |
|---|---|---|
| EIKON THERAPEUTICS, INC. | Directeur Général | 01/05/2021 |
| NGM BIOPHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 08/06/2021 |
Insitro, Inc.
 Insitro, Inc. BiotechnologyHealth Technology Operates as a biology based AI therapeutics company | Directeur/Membre du Conseil | 01/10/2020 |
Exonics Therapeutics, Inc.
 Exonics Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for neuromuscular diseases | Directeur/Membre du Conseil | 30/01/2018 |
The Column Group LLC
 The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Corporate Officer/Principal | - |
The Reed Institute
 The Reed Institute Other Consumer ServicesConsumer Services Functions as a College/University | Président | 21/06/2012 |
Institute for Systems Biology
 Institute for Systems Biology Miscellaneous Commercial ServicesCommercial Services Provides integration of technology, computation, biology and medicine | Directeur/Membre du Conseil | 24/05/2013 |
American Academy of Arts & Sciences
 American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Operates as organization which honours excellence and convenes leaders | Corporate Officer/Principal | - |
Anciens postes connus de Roger Perlmutter
| Sociétés | Poste | Fin |
|---|---|---|
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | President | 01/01/2021 |
| ░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Roger Perlmutter
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
88
Relations au 1er degré
20
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 20 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
StemCells, Inc.
 StemCells, Inc. BiotechnologyHealth Technology Researches and develops stem cell therapeutics | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Washington University in St. Louis
 Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alantos Pharmaceuticals Holding, Inc.
 Alantos Pharmaceuticals Holding, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
NGM Biopharmaceuticals, Inc.
 NGM Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel & life-changing medicines | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Reed Institute
The Reed Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Develops and produces antibodies | Health Technology |
Institute for Systems Biology
Institute for Systems Biology Miscellaneous Commercial ServicesCommercial Services Provides integration of technology, computation, biology and medicine | Commercial Services |
American Academy of Arts & Sciences
American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Operates as organization which honours excellence and convenes leaders | Commercial Services |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
The Irvington Institute for Immunological Research
 The Irvington Institute for Immunological Research Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing biotechnology | Commercial Services |
The American Association of Immunologists
 The American Association of Immunologists Miscellaneous Commercial ServicesCommercial Services The American Association of Immunologists is a professional organization dedicated to advancing immunology research, education, and public understanding of the immune system. The non-profit company is based in Bethesda, MD. It supports the immunology community through programs and resources, including annual meetings, summer courses, specialized programs, career development initiatives, fellowships, awards, travel grants, and mentoring resources. The association publishes two journals, The Journal of Immunology and ImmunoHorizons, and engages in advocacy and public policy related to vaccine policy, NIH funding, and research priorities. It also promotes diversity and inclusion through committees and initiatives for underrepresented minority scientists and provides educational content, public outreach, and advocacy resources. | Commercial Services |
Nxera Pharma UK Ltd.
 Nxera Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Designs and develops new medicines targeting G protein-coupled receptors | Health Technology |
The Column Group LLC
The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Finance |
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical and clinical-stage immunotherapy company | Health Technology |
Exonics Therapeutics, Inc.
Exonics Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for neuromuscular diseases | Health Technology |
Insitro, Inc.
Insitro, Inc. BiotechnologyHealth Technology Operates as a biology based AI therapeutics company | Health Technology |
Eikon Therapeutics, Inc.
 Eikon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical biopharmaceutical and drug discovery company | Health Technology |
Choisissez Zonebourse 
